000909612 001__ 909612
000909612 005__ 20230217124535.0
000909612 0247_ $$2doi$$a10.1007/s00415-022-11260-2
000909612 0247_ $$2ISSN$$a0012-1037
000909612 0247_ $$2ISSN$$a0340-5354
000909612 0247_ $$2ISSN$$a0939-1517
000909612 0247_ $$2ISSN$$a1432-1459
000909612 0247_ $$2ISSN$$a1619-800X
000909612 0247_ $$2Handle$$a2128/33059
000909612 0247_ $$2pmid$$a35802201
000909612 0247_ $$2WOS$$aWOS:000822252300001
000909612 037__ $$aFZJ-2022-03284
000909612 082__ $$a610
000909612 1001_ $$00000-0002-4429-0367$$aKohle, Felix$$b0$$eCorresponding author
000909612 245__ $$aStatus epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry
000909612 260__ $$aBerlin$$bSpringer$$c2022
000909612 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2022-07-08
000909612 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2022-11-01
000909612 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2022-11-01
000909612 3367_ $$2DRIVER$$aarticle
000909612 3367_ $$2DataCite$$aOutput Types/Journal article
000909612 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670912913_32695
000909612 3367_ $$2BibTeX$$aARTICLE
000909612 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000909612 3367_ $$00$$2EndNote$$aJournal Article
000909612 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000909612 542__ $$2Crossref$$i2022-07-08$$uhttps://creativecommons.org/licenses/by/4.0
000909612 542__ $$2Crossref$$i2022-07-08$$uhttps://creativecommons.org/licenses/by/4.0
000909612 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000909612 7001_ $$0P:(DE-HGF)0$$aMadlener, Marie$$b1
000909612 7001_ $$0P:(DE-HGF)0$$aBruno, Emanuel Francesco$$b2
000909612 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b3
000909612 7001_ $$0P:(DE-HGF)0$$aLimmroth, Volker$$b4
000909612 7001_ $$0P:(DE-HGF)0$$aBurghaus, Lothar$$b5
000909612 7001_ $$0P:(DE-HGF)0$$aMalter, Michael Peter$$b6$$eCorresponding author
000909612 77318 $$2Crossref$$3journal-article$$a10.1007/s00415-022-11260-2$$bSpringer Science and Business Media LLC$$d2022-07-08$$n11$$p5710-5719$$tJournal of Neurology$$v269$$x0340-5354$$y2022
000909612 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-022-11260-2$$gVol. 269, no. 11, p. 5710 - 5719$$n11$$p5710-5719$$tJournal of neurology$$v269$$x0340-5354$$y2022
000909612 8564_ $$uhttps://juser.fz-juelich.de/record/909612/files/FINK__Kohle_2022_Journal%20of%20Neurology_Status%20epilepticus%20during%20COVID-19%20pandemic%20in%20Cologne.pdf$$yOpenAccess
000909612 909CO $$ooai:juser.fz-juelich.de:909612$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000909612 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b3$$kFZJ
000909612 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000909612 9141_ $$y2022
000909612 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000909612 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000909612 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000909612 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000909612 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2015
000909612 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000909612 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000909612 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000909612 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000909612 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000909612 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000909612 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000909612 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000909612 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000909612 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000909612 920__ $$lyes
000909612 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000909612 980__ $$ajournal
000909612 980__ $$aVDB
000909612 980__ $$aUNRESTRICTED
000909612 980__ $$aI:(DE-Juel1)INM-3-20090406
000909612 9801_ $$aFullTexts
000909612 999C5 $$1S Knake$$2Crossref$$9-- missing cx lookup --$$a10.1046/j.1528-1157.2001.01101.x$$p714 -$$tEpilepsia$$uKnake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, Katsarou N, Hamer HM (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–718$$v42$$y2001
000909612 999C5 $$1E Trinka$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.13121$$p1515 -$$tEpilepsia$$uTrinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56:1515–1523$$v56$$y2015
000909612 999C5 $$1RJ DeLorenzo$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.46.4.1029$$p1029 -$$tNeurology$$uDeLorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, Fortner CA, Ko D (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029–1035$$v46$$y1996
000909612 999C5 $$1E Dong$$2Crossref$$9-- missing cx lookup --$$a10.1016/S1473-3099(20)30120-1$$p533 -$$tLancet Infect Dis$$uDong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533–534$$v20$$y2020
000909612 999C5 $$1N Zhu$$2Crossref$$9-- missing cx lookup --$$a10.1056/NEJMoa2001017$$p727 -$$tN Engl J Med$$uZhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733$$v382$$y2020
000909612 999C5 $$1C Huang$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0140-6736(20)30183-5$$p497 -$$tLancet$$uHuang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506$$v395$$y2020
000909612 999C5 $$1H Streeck$$2Crossref$$9-- missing cx lookup --$$a10.1038/s41467-020-19509-y$$p5829 -$$tNat Commun$$uStreeck H, Schulte B, Kümmerer BM, Richter E, Höller T, Fuhrmann C, Bartok E, Dolscheid-Pommerich R, Berger M, Wessendorf L, Eschbach-Bludau M, Kellings A, Schwaiger A, Coenen M, Hoffmann P, Stoffel-Wagner B, Nöthen MM, Eis-Hübinger AM, Exner M, Schmithausen RM, Schmid M, Hartmann G (2020) Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany. Nat Commun 11:5829$$v11$$y2020
000909612 999C5 $$1C Karagiannidis$$2Crossref$$9-- missing cx lookup --$$a10.1016/S2213-2600(21)00101-6$$pe47 -$$tLancet Respir Med$$uKaragiannidis C, Windisch W, McAuley DF, Welte T, Busse R (2021) Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med 9:e47–e48$$v9$$y2021
000909612 999C5 $$1A Schuppert$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.lanepe.2021.100151$$p100151 -$$tLancet Reg Health Eur$$uSchuppert A, Polotzek K, Schmitt J, Busse R, Karschau J, Karagiannidis C (2021) Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: a time series study based on national surveillance data. Lancet Reg Health Eur 6:100151–100151$$v6$$y2021
000909612 999C5 $$1D Richter$$2Crossref$$9-- missing cx lookup --$$a10.1161/STROKEAHA.120.033160$$p716 -$$tStroke$$uRichter D, Eyding J, Weber R, Bartig D, Grau A, Hacke W, Krogias C (2021) Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany. Stroke 52:716–721$$v52$$y2021
000909612 999C5 $$1D Aguiar de Sousa$$2Crossref$$9-- missing cx lookup --$$a10.1161/STROKEAHA.120.030792$$p1921 -$$tStroke$$uAguiar de Sousa D, Sandset EC, Elkind MSV (2020) The curious case of the missing strokes during the COVID-19 pandemic. Stroke 51:1921–1923$$v51$$y2020
000909612 999C5 $$1P Berlit$$2Crossref$$9-- missing cx lookup --$$a10.1186/s42466-020-00097-7$$p51 -$$tNeurol Res Pract$$uBerlit P, Bösel J, Gahn G, Isenmann S, Meuth SG, Nolte CH, Pawlitzki M, Rosenow F, Schoser B, Thomalla G, Hummel T (2020) “Neurological manifestations of COVID-19”—guideline of the German society of neurology. Neurol Res Pract 2:51$$v2$$y2020
000909612 999C5 $$1HK Kim$$2Crossref$$9-- missing cx lookup --$$a10.3988/jcn.2021.17.3.435$$p435 -$$tJ Clin Neurol$$uKim HK, Cho YJ, Lee SY (2021) Neurological manifestations in patients with COVID-19: experiences from the central infectious diseases hospital in South Korea. J Clin Neurol 17:435–442$$v17$$y2021
000909612 999C5 $$1AA Asadi-Pooya$$2Crossref$$9-- missing cx lookup --$$a10.1007/s10072-020-04932-2$$p415 -$$tNeurol Sci$$uAsadi-Pooya AA, Simani L, Shahisavandi M, Barzegar Z (2021) COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci 42:415–431$$v42$$y2021
000909612 999C5 $$1JA French$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0000000000009632$$p1032 -$$tNeurology$$uFrench JA, Brodie MJ, Caraballo R, Devinsky O, Ding D, Jehi L, Jette N, Kanner A, Modi AC, Newton CR, Patel AA, Pennell PB, Perucca E, Sander JW, Scheffer IE, Singh G, Williams E, Wilmshurst J, Cross JH (2020) Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology 94:1032–1037$$v94$$y2020
000909612 999C5 $$1DVF Albert$$2Crossref$$9-- missing cx lookup --$$a10.1177/1535759720956994$$p316 -$$tEpilepsy Curr$$uAlbert DVF, Das RR, Acharya JN, Lee JW, Pollard JR, Punia V, Keller JA, Husain AM (2020) The Impact of COVID-19 on epilepsy care: a survey of the American epilepsy society membership. Epilepsy Curr 20:316–324$$v20$$y2020
000909612 999C5 $$1M Belluzzo$$2Crossref$$uBelluzzo M, Nilo A, Valente M, Gigli GL (2021) New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci 2021:1–6$$y2021
000909612 999C5 $$1S Beniczky$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.12270$$p28 -$$tEpilepsia$$uBeniczky S, Hirsch LJ, Kaplan PW, Pressler R, Bauer G, Aurlien H, Brøgger JC, Trinka E (2013) Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 54(Suppl 6):28–29$$v54$$y2013
000909612 999C5 $$1J Rankin$$2Crossref$$9-- missing cx lookup --$$a10.1177/003693305700200504$$p200 -$$tScottish Med J$$uRankin J (1957) Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scottish Med J 2:200–215$$v2$$y1957
000909612 999C5 $$1JC van Swieten$$2Crossref$$9-- missing cx lookup --$$a10.1161/01.STR.19.5.604$$p604 -$$tStroke$$uvan Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607$$v19$$y1988
000909612 999C5 $$1M Leitinger$$2Crossref$$9-- missing cx lookup --$$a10.1007/s12028-014-0080-y$$p273 -$$tNeurocrit Care$$uLeitinger M, Höller Y, Kalss G, Rohracher A, Novak HF, Höfler J, Dobesberger J, Kuchukhidze G, Trinka E (2015) Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care 22:273–282$$v22$$y2015
000909612 999C5 $$1R-J Lv$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.eplepsyres.2017.07.006$$p12 -$$tEpilepsy Res$$uLv R-J, Wang Q, Cui T, Zhu F, Shao X-Q (2017) Status epilepticus-related etiology, incidence and mortality: a meta-analysis. Epilepsy Res 136:12–17$$v136$$y2017
000909612 999C5 $$1DC Hesdorffer$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.50.3.735$$p735 -$$tNeurology$$uHesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 50:735–741$$v50$$y1998
000909612 999C5 $$1JP Betjemann$$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(15)00042-3$$p615 -$$tLancet Neurol$$uBetjemann JP, Lowenstein DH (2015) Status epilepticus in adults. Lancet Neurol 14:615–624$$v14$$y2015
000909612 999C5 $$2Crossref$$uKoeln S (2021) Bevölkerungszahl sinkt leicht auf 1 088 040 in 2020. Available from: https://www.stadt-koeln.de/mediaasset/content/pdf15/statistik-einwohner-und-haushalte/kurzinformation_bev%C3%B6lkerung_3_2021.pdf
000909612 999C5 $$1D Bhalla$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.seizure.2014.06.009$$p769 -$$tSeizure$$uBhalla D, Tchalla AE, Mignard C, Marin B, Mignard D, Jallon P, Preux P-M (2014) First-ever population-based study on status epilepticus in French Island of La Reunion (France)—incidence and fatality. Seizure 23:769–773$$v23$$y2014
000909612 999C5 $$1V Govoni$$2Crossref$$9-- missing cx lookup --$$a10.1159/000111873$$p120 -$$tEur Neurol$$uGovoni V, Fallica E, Monetti VC, Guerzoni F, Faggioli R, Casetta I, Granieri E (2008) Incidence of status epilepticus in Southern Europe: a population study in the Health District of Ferrara, Italy. Eur Neurol 59:120–126$$v59$$y2008
000909612 999C5 $$1M Leitinger$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.14607$$p53 -$$tEpilepsia$$uLeitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U (2019) Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 60:53–62$$v60$$y2019
000909612 999C5 $$1RJ DeLorenzo$$2Crossref$$9-- missing cx lookup --$$a10.1097/00004691-199512040-00003$$p316 -$$tJ Clin Neurophysiol$$uDeLorenzo RJ, Pellock JM, Towne AR, Boggs JG (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12:316–325$$v12$$y1995
000909612 999C5 $$1PS Bergin$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.16277$$p1552 -$$tEpilepsia$$uBergin PS, Brockington A, Jayabal J, Scott S, Litchfield R, Roberts L, Timog J, Beilharz E, Dalziel SR, Jones P, Yates K, Thornton V, Walker EB, Davis S, Te Ao B, Parmar P, Beghi E, Rossetti AO, Feigin V (2019) Status epilepticus in Auckland, New Zealand: incidence, etiology, and outcomes. Epilepsia 60:1552–1564$$v60$$y2019
000909612 999C5 $$1G Pauletto$$2Crossref$$uPauletto G, Nilo A, Deana C, Verriello L, Del Negro I, Lettieri C, Vetrugno L, Valente M, Gigli GL (2021) Recurrent status epilepticus and SARS-CoV-2 infection: the “perfect storm.” Acta Biomed 92:e2021208$$y2021
000909612 999C5 $$1M Leitinger$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.16737$$pe198 -$$tEpilepsia$$uLeitinger M, Poppert KN, Mauritz M, Rossini F, Zimmermann G, Rohracher A, Kalss G, Kuchukhidze G, Höfler J, Bosque Varela P, Kreidenhuber R, Volna K, Neuray C, Kobulashvili T, Granbichler CA, Siebert U, Trinka E (2020) Status epilepticus admissions during the COVID-19 pandemic in Salzburg-A population-based study. Epilepsia 61:e198–e203$$v61$$y2020
000909612 999C5 $$1TM Mueller$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.yebeh.2021.107833$$p107833 -$$tEpilepsy Behav$$uMueller TM, Kostev K, Gollwitzer S, Lang JD, Stritzelberger J, Westermayer V, Reindl C, Hamer HM (2021) The impact of the coronavirus disease (COVID-19) pandemic on outpatient epilepsy care: an analysis of physician practices in Germany. Epilepsy Behav 117:107833–107833$$v117$$y2021
000909612 999C5 $$1JH Cross$$2Crossref$$9-- missing cx lookup --$$a10.1111/epi.17045$$p2322 -$$tEpilepsia$$uCross JH, Kwon CS, Asadi-Pooya AA, Balagura G, Gómez-Iglesias P, Guekht A, Hall J, Ikeda A, Kishk NA, Murphy P, Kissani N, Naji Y, Perucca E, Pérez-Poveda JC, Sanya EO, Trinka E, Zhou D, Wiebe S, Jette N (2021) Epilepsy care during the COVID-19 pandemic. Epilepsia 62:2322–2332$$v62$$y2021
000909612 999C5 $$1G Assenza$$2Crossref$$9-- missing cx lookup --$$a10.3389/fneur.2020.00737$$p737 -$$tFront Neurol$$uAssenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, Ricci L, Romigi A, Tombini M, Mecarelli O (2020) Epilepsy care in the time of COVID-19 Pandemic in Italy: risk factors for seizure Worsening. Front Neurol 11:737$$v11$$y2020
000909612 999C5 $$1AP Kansagra$$2Crossref$$9-- missing cx lookup --$$a10.1056/NEJMc2014816$$p400 -$$tN Engl J Med$$uKansagra AP, Goyal MS, Hamilton S, Albers GW (2020) Collateral effect of Covid-19 on stroke evaluation in the United States. N Engl J Med 383:400–401$$v383$$y2020
000909612 999C5 $$1D Schöppenthau$$2Crossref$$uSchöppenthau D, Weiß KJ, Estepa-Martinez M, Hommel M, Miera O, Schoenrath F, Hübler S, Obermeier M, Pieske B, Stawowy P (2021) Preventing SARS-CoV-2 in-hospital infections in cardiovascular patients and medical staff: an observational study from the German Heart Center Berlin. Front Med 2021:7$$y2021